Cannabinoid CB2 Receptor Activation Attenuates Motor and Autonomic Function Deficits in a Mouse Model of Spinal Cord Injury

Authors:
  • DBDarric E. Baty
    Darric E. Baty
  • MZMing Zhang
    Ming Zhang
  • HLHongbo Li
    Hongbo Li
  • CECarolyn J. Erb
    Carolyn J. Erb
  • DGDoina Ganea
    Doina Ganea
  • CLChristopher M. Loftus
    Christopher M. Loftus
  • JJJack Jallo
    Jack Jallo
  • RTRonald F. Tuma
    Ronald F. Tuma

Abstract
INTRODUCTION: Spinal cord injury (SCI) is a significant health problem in the United States, with few effective medical treatments. Murine models of central nervous system diseases such as stroke and multiple sclerosis have demonstrated inflammatory response modulation with cannabinoid CB2 receptor (CB2) activation; however, the role of CB2 activation after SCI has not been previously explored. To this end, we investigate the effect of CB2 agonist administration on functional outcome in a SCI mouse contusion model.